113 related articles for article (PubMed ID: 7704960)
1. The IGF-I receptor sub-membrane domain is intact in GH-secreting pituitary tumours.
Greenman Y; Prager D; Melmed S
Clin Endocrinol (Oxf); 1995 Feb; 42(2):169-72. PubMed ID: 7704960
[TBL] [Abstract][Full Text] [Related]
2. Reduced expression of the growth hormone and type 1 insulin-like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptor.
Kola B; Korbonits M; Diaz-Cano S; Kaltsas G; Morris DG; Jordan S; Metherell L; Powell M; Czirják S; Arnaldi G; Bustin S; Boscaro M; Mantero F; Grossman AB
Clin Endocrinol (Oxf); 2003 Sep; 59(3):328-38. PubMed ID: 12919156
[TBL] [Abstract][Full Text] [Related]
3. Structure of the thyrotrophin-releasing hormone receptor in human pituitary adenomas.
Faccenda E; Melmed S; Bevan JS; Eidne KA
Clin Endocrinol (Oxf); 1996 Mar; 44(3):341-7. PubMed ID: 8729534
[TBL] [Abstract][Full Text] [Related]
4. Identification of G protein alpha subunit mutations in human growth hormone (GH)- and GH/prolactin-secreting pituitary tumors by single-strand conformation polymorphism (SSCP) analysis.
Drews RT; Gravel RA; Collu R
Mol Cell Endocrinol; 1992 Sep; 87(1-3):125-9. PubMed ID: 1446784
[TBL] [Abstract][Full Text] [Related]
5. Absence of mutations in the growth hormone (GH)-releasing hormone receptor gene in GH-secreting pituitary adenomas.
Salvatori R; Thakker RV; Lopes MB; Fan X; Eswara JR; Ellison D; Lees P; Harding B; Yang I; Levine MA
Clin Endocrinol (Oxf); 2001 Mar; 54(3):301-7. PubMed ID: 11298081
[TBL] [Abstract][Full Text] [Related]
6. p16 (INK4a, MTS-1) gene polymorphism and methylation status in human pituitary tumours.
Jaffrain-Rea ML; Ferretti E; Toniato E; Cannita K; Santoro A; Di Stefano D; Ricevuto E; Maroder M; Tamburrano G; Cantore G; Gulino A; Martinotti S
Clin Endocrinol (Oxf); 1999 Sep; 51(3):317-25. PubMed ID: 10469011
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone receptor mRNA expression in non-functioning and somatotroph pituitary adenomas: implications for growth hormone substitution therapy?
Beuschlein F; Hancke K; Petrick M; Göbel H; Honegger J; Reincke M
Exp Clin Endocrinol Diabetes; 2005 Apr; 113(4):214-8. PubMed ID: 15891957
[TBL] [Abstract][Full Text] [Related]
8. IGF-I receptor signalling: lessons from the somatotroph.
Melmed S; Yamashita S; Yamasaki H; Fagin J; Namba H; Yamamoto H; Weber M; Morita S; Webster J; Prager D
Recent Prog Horm Res; 1996; 51():189-215; discussion 215-6. PubMed ID: 8701079
[TBL] [Abstract][Full Text] [Related]
9. GH-secreting pituitary adenomas infrequently contain inactivating mutations of PRKAR1A and LOH of 17q23-24.
Yamasaki H; Mizusawa N; Nagahiro S; Yamada S; Sano T; Itakura M; Yoshimoto K
Clin Endocrinol (Oxf); 2003 Apr; 58(4):464-70. PubMed ID: 12641630
[TBL] [Abstract][Full Text] [Related]
10. Expression of pituitary tumour-derived, N-terminally truncated isoform of fibroblast growth factor receptor 4 (ptd-FGFR4) correlates with tumour invasiveness but not with G-protein alpha subunit (gsp) mutation in human GH-secreting pituitary adenomas.
Morita K; Takano K; Yasufuku-Takano J; Yamada S; Teramoto A; Takei M; Osamura RY; Sano T; Fujita T
Clin Endocrinol (Oxf); 2008 Mar; 68(3):435-41. PubMed ID: 18070145
[TBL] [Abstract][Full Text] [Related]
11. Absence of somatostatin receptor type 2 A mutations and gip oncogene in pituitary somatotroph adenomas.
Petersenn S; Heyens M; Lüdecke DK; Beil FU; Schulte HM
Clin Endocrinol (Oxf); 2000 Jan; 52(1):35-42. PubMed ID: 10651751
[TBL] [Abstract][Full Text] [Related]
12. Human insulin-like growth factor I receptor 950tyrosine is required for somatotroph growth factor signal transduction.
Yamasaki H; Prager D; Gebremedhin S; Melmed S
J Biol Chem; 1992 Oct; 267(29):20953-8. PubMed ID: 1400411
[TBL] [Abstract][Full Text] [Related]
13. Sequence analysis of the PRKAR1A gene in sporadic somatotroph and other pituitary tumours.
Kaltsas GA; Kola B; Borboli N; Morris DG; Gueorguiev M; Swords FM; Czirják S; Kirschner LS; Stratakis CA; Korbonits M; Grossman AB
Clin Endocrinol (Oxf); 2002 Oct; 57(4):443-8. PubMed ID: 12354125
[TBL] [Abstract][Full Text] [Related]
14. GSPalpha mutations in Mexican patients with acromegaly: potential impact on long term prognosis.
Mendoza V; Sosa E; Espinosa-de-Los-Monteros AL; Salcedo M; Guinto G; Cheng S; Sandoval C; Mercado M
Growth Horm IGF Res; 2005 Feb; 15(1):28-32. PubMed ID: 15701569
[TBL] [Abstract][Full Text] [Related]
15. Rat somatotroph insulin-like growth factor-II (IGF-II) signaling: role of the IGF-I receptor.
Weber MM; Melmed S; Rosenbloom J; Yamasaki H; Prager D
Endocrinology; 1992 Nov; 131(5):2147-53. PubMed ID: 1425415
[TBL] [Abstract][Full Text] [Related]
16. Structure-function of the human insulin-like growth factor-I receptor: a discordance of somatotroph internalization and signaling.
Yamasaki H; Prager D; Melmed S
Mol Endocrinol; 1993 May; 7(5):681-5. PubMed ID: 8316251
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the intracellular mechanisms mediating somatostatin and lanreotide inhibition of DNA synthesis and growth hormone release from dispersed human GH-secreting pituitary adenoma cells in vitro.
Florio T; Thellung S; Corsaro A; Bocca L; Arena S; Pattarozzi A; Villa V; Massa A; Diana F; Schettini D; Barbieri F; Ravetti JL; Spaziante R; Giusti M; Schettini G
Clin Endocrinol (Oxf); 2003 Jul; 59(1):115-28. PubMed ID: 12807513
[TBL] [Abstract][Full Text] [Related]
18. Molecular screening of pituitary adenomas for gene mutations and rearrangements.
Herman V; Drazin NZ; Gonsky R; Melmed S
J Clin Endocrinol Metab; 1993 Jul; 77(1):50-5. PubMed ID: 8100831
[TBL] [Abstract][Full Text] [Related]
19. The sensitivity of growth hormone secretion to medical treatment in acromegalic patients: influence of age and sex.
van der Lely AJ; Harris AG; Lamberts SW
Clin Endocrinol (Oxf); 1992 Aug; 37(2):181-5. PubMed ID: 1395069
[TBL] [Abstract][Full Text] [Related]
20. Analysis of GNAS mutations in 60 growth hormone secreting pituitary tumors: correlation with clinical and pathological characteristics and surgical outcome based on highly sensitive GH and IGF-I criteria for remission.
Freda PU; Chung WK; Matsuoka N; Walsh JE; Kanibir MN; Kleinman G; Wang Y; Bruce JN; Post KD
Pituitary; 2007; 10(3):275-82. PubMed ID: 17594522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
